Chester County News and Community Website
The U.S. Food and Drug Administration recently approved Vowst, the first fecal microbiota product that is taken orally. Vowst is approved for the prevention of recurrence of Clostridioides difficile (C. difficile) …
FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) this week announced that the Company was notified via verbal communication from the U.S. Food and Drug Administration (FDA) that the AB-101 …
Arbutus Announces FDA Clinical Hold on IND Application for AB-101 Read More
DELAWARE — Early in March, Insurance Commissioner Trinidad Navarro and Cristine Vogel, the Director of the Department’s Office of Value-Based Health Care Delivery, issued the Annual Review of Carrier Progress …
Delaware Office of Value-Based Health Care Delivery Issues Annual Progress Report Read More
The U.S. Food and Drug Administration recently approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood …
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation Read More